GSK were alerted to counterfeit products by customers.  On inspection of the packaging there was a number of inconsistencies between the authentic and fake packs the difference in the product however are more serious.

This is yet another counterfeit issue  raised, surely this case and others demonstrate the size of the  opportunities for the packaging industry to deliver smart and cost effective solutions.

Annie Dallison

FDA is warning consumers about counterfeit Alli reportedly sold over the Internet. Testing by manufacturer GlaxoSmithKline has revealed that the fake products contain the controlled substance sibutramine, not contain orlistat, the active ingredient in its product. FDA warns that this fake version of Alli 60 mg capsules (120 count refill kit) could be harmful if used improperly.

Via PPM News 20th January 2010. You can read the full article by clicking: http://bit.ly/5y3Pxy

Tags: counterfeit, healthcare, packaging, pharma

This entry was posted on Wednesday, January 20th, 2010 at 12:40 pm and is filed under Design, Healthcare & Pharma, Marketing, Safety. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.